- Molecular testing of HER2/neu of patients with breast cancer as a criterium for selection of Herceptin therapy- is our approach optimal?2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The advantage of Herceptin SC and advantage of the originator2017 | Faculty of Medicine in Pilsen
- Effect of neoadjuvant Herceptin (trastuzumab) in a patient with breast cancer with high growth activity2009 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. B3271004Publication without faculty affiliation
- Quantitative RT-PCR as a tool solving discerepant results between ERBB2 gene coopy numbers and expression of the ERBB-2 protein: An improvement of Herceptin therapy indication in breast carcinomas2002 | Central Library of Charles University, Second Faculty of Medicine
- Therapy Indication of Patients with Invasive Duct Carcinomas of the Breast for Herceptin from the Point of Laboratory Diagnostics- Investigation of ERBB-2 Protein Expression and Copy Numbers of the ERBB2 Gene. A Rewiev.2002 | Central Library of Charles University, Second Faculty of Medicine
- Nový způsob úhrady přípravků Herceptin a Perjeta2014 | First Faculty of Medicine
- Multinational phase II study of navelbine (N) and herceptin (H) as first-line trerapy for HER2-overexpressing metastatic breast Cancer (HER2+MBC)Publication without faculty affiliation
- Quantitative RT-PCR as a tool solving discerepant results between ERBB2 gene copy numbers and expression of the ERBB -2 protein: An improvement of Herceptin therapy indication in breast carcinomasPublication without faculty affiliation
- Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients2017 | Publication without faculty affiliation
- Correlation of c-erbB-2 Gene Expression (Detected by FISH) with Membrane Expression of erbB-2 Protein (Detected by IHC) in Patients with Primary Breast Carcinomas2001 | Second Faculty of Medicine
- Use of Trastuzumab for Neoadjuvant Therapy of HER2+ Breast Cancer - 5-Years of Experience in a Single Clinic2018 | First Faculty of Medicine
- Immunotherapy - Perspectives of Application in the Therapy of Ovarian Carcinomas2004 | Second Faculty of Medicine
- A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system2007 | Second Faculty of Medicine
- Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D12003 | Second Faculty of Medicine
- Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: Correlation with ERBB-2 protein expression and ERBB2 gene copy number2003 | Second Faculty of Medicine
